Business Context and Reporting Period
This Form 6-K filing by Mobile-Health Network Solutions covers the month of May 2025, with the report dated May 5, 2025. The Company is a foreign private issuer based in Singapore. The filing primarily discloses the execution of a non-binding term sheet for the acquisition of Indopacific Health Investment Corporation Pte. Ltd., an Indonesia-based digital pharmacy and telehealth platform, and the subsequent entry into a definitive securities purchase agreement for interim financing.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, or debt levels for the reporting period. The only specific financial data disclosed relates to a recent capital raise:
- Interim Financing Amount: $200,000
- Shares Issued: 112,423 Class A ordinary shares
- Price Per Share: $1.779
- Use of Proceeds: Contribution to Indopacific as a commitment fee for the proposed share exchange.
Material Changes
The primary material change is the progression of the proposed acquisition of Indopacific:
- April 4, 2025: Execution of a non-binding term sheet for a share exchange acquisition.
- May 2, 2025: Execution of a definitive Securities Purchase Agreement (SPA) to raise $200,000 in interim financing to support the transaction.
- Current Status: As of May 5, 2025, the parties have not yet entered into a definitive agreement for the Share Exchange itself, only the financing agreement.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the ability to successfully execute the acquisition plans. Management notes that these statements involve substantial risks and uncertainties.
- Conditions Precedent: The closing of the share sale is conditioned on the approval and designation of the Consideration Shares for quotation or listing on the Nasdaq Capital Market.
- Lock-up Period: Purchasers (Indopacific and Natali Ardianto) agreed not to transfer the securities for six months post-issuance.
- Regulatory Status: The shares were issued unregistered under Section 4(a)(2) of the Securities Act and Regulation D.
- Future Announcements: The Company will issue a further announcement once a definitive agreement for the Share Exchange is executed.
Investor Verification Checklist
- Verify the status of the Nasdaq Capital Market listing approval for the newly issued shares, as this is a condition for closing the financing.
- Monitor for the execution of the definitive Share Exchange agreement, which has not yet been signed.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for additional covenants or representations not summarized in the filing.
- Confirm the regulatory standing of the unregistered share issuance under Section 4(a)(2) and Regulation D.